Albrioza (sodium phenylbutyrate and ursodoxicoltaurine)
pCPA File Number:
21945
Negotiation Status:
Concluded with an LOI
Indication(s):
Amyotrophic Lateral Sclerosis (ALS)
Sponsor/Manufacturer:
Amylyx Canada
CDA-AMC Project Number:
SR0711-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: